PCJ Investment Counsel’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Buy
29,290
+5,360
+22% +$382K 0.63% 51
2025
Q4
$1.48M Sell
23,930
-4,170
-15% -$245K 0.37% 54
2025
Q3
$1.65M Buy
28,100
+3,370
+14% +$196K 0.46% 53
2025
Q2
$1.44M Buy
24,730
+1,020
+4% +$57.6K 0.49% 55
2025
Q1
$1.18M Buy
+23,710
New +$1.21M 0.46% 51
2024
Q4
Sell
-13,290
Closed -$639K 79
2024
Q3
$639K Sell
13,290
-4,610
-26% -$222K 0.2% 68
2024
Q2
$911K Buy
+17,900
New +$980K 0.38% 68
2024
Q1
Sell
-31,230
Closed -$1.76M 88
2023
Q4
$1.76M Buy
31,230
+1,400
+5% +$79.1K 0.68% 48
2023
Q3
$1.84M Buy
29,830
+4,510
+18% +$285K 0.85% 41
2023
Q2
$1.49M Sell
25,320
-2,285
-8% -$145K 0.63% 55
2023
Q1
$2.04M Sell
27,605
-1,650
-6% -$127K 0.81% 42
2022
Q4
$2.14M Sell
29,255
-15,560
-35% -$1.23M 0.93% 41
2022
Q3
$3.73M Buy
44,815
+4,960
+12% +$427K 1.83% 23
2022
Q2
$3.17M Sell
39,855
-20,970
-34% -$2.04M 1.57% 21
2022
Q1
$6.29M Sell
60,825
-36,520
-38% -$3.03M 2.3% 13
2021
Q4
$7.32M Buy
97,345
+41,750
+75% +$2.92M 2.58% 13
2021
Q3
$3.6M Sell
55,595
-3,710
-6% -$227K 1.3% 30
2021
Q2
$3.59M Sell
59,305
-28,770
-33% -$1.7M 1.35% 29
2021
Q1
$4.74M Buy
88,075
+18,760
+27% +$1.02M 1.87% 21
2020
Q4
$3.33M Buy
69,315
+6,110
+10% +$270K 1.56% 23
2020
Q3
$2.48M Buy
+63,205
New +$2.3M 1.13% 28
2020
Q2
Sell
-47,106
Closed -$1.61M 79
2020
Q1
$1.61M Buy
47,106
+2,762
+6% +$111K 1.11% 28
2019
Q4
$2.13M Sell
44,344
-13,980
-24% -$676K 0.96% 29
2019
Q3
$2.91M Sell
58,324
-268,814
-82% -$13.7M 1.51% 24
2019
Q2
$17.5M Sell
327,138
-191,643
-37% -$10M 1.88% 23
2019
Q1
$27.4M Sell
518,781
-91,020
-15% -$4.74M 2.24% 15
2018
Q4
$28.6M Sell
609,801
-57,550
-9% -$3M 2.66% 14
2018
Q3
$38.5M Buy
667,351
+56,720
+9% +$3.14M 3.15% 13
2018
Q2
$33.2M Buy
610,631
+135,063
+28% +$6.7M 2.18% 17
2018
Q1
$22.5M Buy
+475,568
New +$23.8M 1.56% 22

Other funds holding NTR

PCJ Investment Counsel's NTR Position: Q1 2026 in Review

PCJ Investment Counsel increased its Nutrien (NTR) stake by 22% in Q1 2026, buying an estimated $382K and bringing the position to 29,290 shares worth $2.21M. The position accounts for 0.63% of the portfolio, ranked #51.

PCJ Investment Counsel first reported a position in NTR in Q1 2018 and has held it in 30 quarters since. The position peaked at $38.5M in Q3 2018. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • PCJ Investment Counsel held 29,290 shares of Nutrien worth $2.21M as of Q1 2026.
  • PCJ Investment Counsel bought 5,360 Nutrien shares in Q1 2026, an estimated $382K.
  • Nutrien made up 0.63% of PCJ Investment Counsel's portfolio in Q1 2026, its #51 holding.
  • PCJ Investment Counsel first reported a position in Nutrien in Q1 2018 and has held it in 30 quarters since.
  • PCJ Investment Counsel's Nutrien position peaked at $38.5M in Q3 2018.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on PCJ Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.